Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(12): 2068-2072, 2023 Dec 06.
Article in Chinese | MEDLINE | ID: mdl-38186158

ABSTRACT

Objective: To understand the changes in pain and its effects in patients with the diagnosis of herpes zoster. Methods: A total of 3 487 patients diagnosed with herpes zoster (HZ) for the first time at the outpatient department of Miyun District Hospital from January 1, 2017, to December 31, 2019, were included in the study. The information of patients was registered and issued with a record card. Patients were required to record the time of pain and rash by themselves. Telephone follow-up was conducted at 21, 90, 180 and 365 days after the onset of rashes, including hospitalization, location of rash and pain, and the time of start and end. The impact of pain on life was evaluated by the Zoster Brief Pain Inventory (ZBPI). Results: The age of 2 999 HZ patients included in the analysis were (53±16) years old, including 1 377 (45.91%) males and 1 903 (63.45%) patients aged 50 years and older. After 21 days of rash, mild, moderate and severe pain accounted for 20.87% (626 cases), 37.98% (1 139 cases) and 33.81% (1 014 cases), respectively. Only 5.07% (152 cases) had no pain or discomfort, and 2.27% (68 cases) had no pain but discomfort. Most of the pain sites were consistent with the rash sites. The chest and back and waist and abdomen were the most common, accounting for 35.58% (1 067 cases) and 29.18% (875 cases), respectively, followed by the limbs and face and neck, accounting for 16.74% (502 cases) and 16.40% (492 cases), respectively. The M (Q1, Q3) of pain days in the HZ patients was 14 (8, 20) days, and the incidence of post-herpetic neuralgia (PHN) was 6.63% (171/2 580) (excluding 419 patients who refused to visit or lost to visit on 90 days after the onset of rash). The pain score of HZ patients within 21 days after the rash was (5.19±2.73) points, and the pain score of PHN patients was (7.61±2.13) points, which was significantly higher than that of non-PHN patients [(5.04±2.69) points] (P<0.001). Daily activities, emotions, walking ability, work, social interaction, sleep and recreation were affected for 21 days after the rash in HZ patients, ranging from 60.79% to 83.83%, with sleep being the most affected (83.83%). The impact scores of pain and life dimensions in PHN patients ranged from 4.59 to 7.61 points on the ZBPI scale, which were higher than those in non-PHN patients (2.49-5.04) (t values ranged from 8.86 to 11.67, all P values <0.001). Conclusion: The proportion of pain in HZ patients after the diagnosis is high, and the pain is more obvious in patients with PHN and HZ patients aged 50 and older, which has a greater impact on their daily lives.


Subject(s)
Exanthema , Herpes Zoster , Male , Humans , Middle Aged , Aged , Adult , Female , Beijing , Follow-Up Studies , Herpes Zoster/epidemiology , Pain/epidemiology
2.
Zhonghua Yu Fang Yi Xue Za Zhi ; 54(7): 779-783, 2020 Jul 06.
Article in Chinese | MEDLINE | ID: mdl-32842302

ABSTRACT

Objective: To analyze the changing trend of polio vaccine immunization effectiveness and vaccine titer in Beijing in 2012, 2014, 2016 and 2018 before and after the adjustment of polio vaccine immunization program strategy. Methods: According to the convenient sampling method,the vaccination clinics of Chaoyang and Yanqing Districts in 2012, Fengtai and Daxing Districts in 2014, Tongzhou and Pinggu Districts in 2016, Dongcheng and Shunyi Districts in 2018 were selected as monitoring points. A total of 292 children were selected 4-8 weeks after the completion of 3 doses polio vaccine basic immunization which were 3 doses of trivalent oral poliovirus vaccine(tOPV)schedule before the strategy adjustment in 2012-2014 and 1 dose of inactivated poliovirus vaccine (IPV) following 2 doses of bivalent oral poliovirus vaccine (bOPV) sequential schedule after the adjustment in 2016-2018. About 1.0 ml blood samples were collected to detect type Ⅰ and Ⅲ neutralizing poliovirus antibody. A total of 9 oral poliovirus vaccines (8 vaccines in 2012) were selected from different sources of vaccine storage every year to test the vaccine titer using random number method. Results: The [M(P25,P75)] age of 292 children was 5 (5, 6) months, and the ratio of male to female was 1.04 (149/143). In 2012, 2014, 2016 and 2018, 66,72,68 and 86 children were investigated respectively. After basic immunization, antibody positive rates for type Ⅰ and Ⅲ poliovirus were 100%, except 98.61% (71) for type Ⅰ poliovirus in 2014. The neutralizing antibody titer of type Ⅰ and Ⅲ poliovirus was higher in 2016 and 2018 than that in 2012 and 2014 (P<0.001). The average titer of tOPV were (6.05±0.15) and (6.16±0.12) lgCCID50 per dose in 2012 and 2014. The average titer of bOPV were (6.88±0.21) and (6.26±0.14) lgCCID50 per 100 µl in 2016 and 2018 (P<0.001). Conclusion: Before and after the adjustment of polio vaccine immunization strategy in Beijing, the basic immunization success rate of the IPV-bOPV sequential immunization schedule was good as well as full tOPV schedule. The level of polio antibody produced by the IPV-bOPV sequential immunization schedule was higher. After adjustment, bOPV titer in 2016 was significantly higher than those before adjustment, while bOPV titer decreased significantly in 2018.


Subject(s)
Poliomyelitis/prevention & control , Poliovirus , Beijing , Child , Female , Humans , Immunization Programs , Immunization Schedule , Infant , Male , Poliovirus Vaccine, Inactivated , Poliovirus Vaccine, Oral , Vaccination
3.
Zhonghua Liu Xing Bing Xue Za Zhi ; 41(7): 1138-1144, 2020 Jul 10.
Article in Chinese | MEDLINE | ID: mdl-32741184

ABSTRACT

Objective: To assess the effectiveness of 1 dose varicella attenuated live vaccine (VarV) for healthy children aged 1-12 years in China and explore the application of the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) framework in observational studies of vaccine effectiveness (VE). Methods: We searched studies about the VE of 1-dose VarV for children aged 1-12 years in China which published before 2019 and evaluated the quality of the studies by the Newcastle Ottawa Scale (NOS) table. We used Meta-analysis models to obtain the pooled 1-dose VE and that in subgroups by study design, outbreak or not, study quality and age of subjects. The evidences of VEs were rated by means of the GRADE system. Results: Thirty-two studies were included and the pooled 1-dose VE was 75% [95% confidence interval (CI): 68%-80%]. The VE of outbreak studies [VE=66% (95%CI: 57%-73%)] was lower than non-outbreak studies [VE=85% (95%CI: 78%-89%)], and the VE in <6 years old children [VE=84% (95%CI:77%-89%)] was higher than that in ≥6 years old children [VE=60% (95%CI: 51%-68%)]. There was no significant difference in VE among studies with different design and quality. The quality of the evidences of pooled 1-dose VE was"very low", which was downgraded in bias risk and inconsistency and not downgraded in indirectness, imprecision and publication bias. Conclusions: The 1-dose VarV can provide medium level protection for 1-12 years old children in China, but it will decrease significantly for ≥6 years old children, so it is suggested to implement the strategies of two-dose vaccination of VarV in children <6 years old. The GRADE framework can be used in the observational studies of VE and it is suggested that the technical guidelines of observational study should be worked out to improve the overall quality of evidence.


Subject(s)
Chickenpox Vaccine/administration & dosage , Chickenpox Vaccine/immunology , Chickenpox/prevention & control , Disease Outbreaks/prevention & control , Chickenpox/epidemiology , Child , Child, Preschool , China/epidemiology , Dose-Response Relationship, Immunologic , Humans , Infant , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology
4.
Zhonghua Yu Fang Yi Xue Za Zhi ; 53(5): 503-507, 2019 May 06.
Article in Chinese | MEDLINE | ID: mdl-31091609

ABSTRACT

Objective: Using data of health information system (HIS) of medical institutions to study the incidence and hospitalization of herpes zoster in three districts of Beijing. Methods: According to the different level of economic development and geographical features in Beijing, 3 districts of Xicheng, Changping and Miyun were chosen and all 110 medical institutions of the first level and above in the 3 districts are included in the survey. All the outpatient and inpatient herpes zoster cases in 2015 were retrospectively reviewed by HIS system. After distinguishing the reduplicated cases, Using the first outpatient case as a molecule and the resident population as denominator to estimate the annual incidence rate, as well as the annual hospitalization rate was estimated based on primary diagnostic hospitalized cases as molecule and the resident population as denominator. Results: A total of 32 313 primary visit outpatient cases were investigated, of which 18 360 cases (56.8%) were women and 20 923 cases (64.8%) were ≥50 years old. The overall estimated incidence of the 3 districts was 8.8‰ with an increase trends with age and reached to the highest in ≥80 years old (30.5/1 000). The incidence of Xicheng, Changping and Miyun districts are respectively 16.2‰, 4.0‰ and 5.7‰. A total of 701 primary visit inpatient cases were identified, of which 366 cases (52.2%) were women and 651 cases (92.9%) were ≥50 years old. The estimated annual hospitalization rate was 19.4/100 000, with the primary and secondary diagnostic hospitalization rate are respectively 5.9/100 000 (212 cases) and 13.5/100 000 (489 cases). The disease types of secondary diagnostic inpatient herpes zoster cases were as follows: cardiovascular disease (19.0%, 93 cases), stroke (14.5%, 71 cases), pneumonia/chronic obstructive pulmonary disease (14.1%, 69 cases), tumor (12.5%, 61 cases) and diabetes (5.7%, 28 cases). Conclusion: Most of the herpes zoster cases in Beijing are over 50 years old, and the incidence of female is slightly higher than male. This disease should become a public health issue of great concern.


Subject(s)
Herpes Zoster/epidemiology , Hospitalization/statistics & numerical data , Aged, 80 and over , Beijing/epidemiology , Female , Health Information Systems , Herpes Zoster/therapy , Hospitals , Humans , Incidence , Male , Middle Aged , Retrospective Studies
5.
Nat Mater ; 16(7): 717-721, 2017 07.
Article in English | MEDLINE | ID: mdl-28604716

ABSTRACT

Two-dimensional (2D) materials have been studied extensively as monolayers, vertical or lateral heterostructures. To achieve functionalization, monolayers are often patterned using soft lithography and selectively decorated with molecules. Here we demonstrate the growth of a family of 2D materials that are intrinsically patterned. We demonstrate that a monolayer of PtSe2 can be grown on a Pt substrate in the form of a triangular pattern of alternating 1T and 1H phases. Moreover, we show that, in a monolayer of CuSe grown on a Cu substrate, strain relaxation leads to periodic patterns of triangular nanopores with uniform size. Adsorption of different species at preferred pattern sites is also achieved, demonstrating that these materials can serve as templates for selective self-assembly of molecules or nanoclusters, as well as for the functionalization of the same substrate with two different species.

6.
Genet Mol Res ; 14(4): 15390-8, 2015 Nov 30.
Article in English | MEDLINE | ID: mdl-26634504

ABSTRACT

Various plant genes can be activated or inhibited by phytohormones under conditions of biotic and abiotic stress, especially in response to jasmonic acid (JA) and salicylic acid (SA). Interactions between JA and SA may be synergistic or antagonistic, depending on the stress condition. In this study, we cloned a full-length cDNA (LeWRKY1, GenBank accession No. FJ654265) from Lycopersicon esculentum by rapid amplification of cDNA ends. Sequence analysis showed that this gene is a group II WRKY transcription factor. Analysis of LeWRKY1 mRNA expression in various tissues by qRT-PCR showed that the highest and lowest expression occurred in the leaves and stems, respectively. In addition, LeWRKY1 expression was induced by JA and Botrytis cinerea Pers., but not by SA.


Subject(s)
Cyclopentanes/metabolism , Genes, Plant/genetics , Oxylipins/metabolism , Plant Proteins/genetics , Salicylic Acid/metabolism , Solanum lycopersicum/genetics , Botrytis/metabolism , Cloning, Molecular/methods , DNA, Complementary/genetics , Gene Expression Regulation, Plant/genetics , Plant Growth Regulators/genetics , Plant Leaves/genetics , Plant Stems/genetics , RNA, Messenger/genetics , Transcription Factors/genetics
7.
Genet Mol Res ; 13(1): 310-22, 2014 Jan 21.
Article in English | MEDLINE | ID: mdl-24535858

ABSTRACT

MicroRNAs (miRNAs) are a class of non-coding small RNAs that negatively regulate gene expression at the post-transcriptional level. Although thousands of miRNAs have been identified in plants, limited information is available about miRNAs in Phaseolus vulgaris, despite it being an important food legume worldwide. The high conservation of plant miRNAs enables the identification of new miRNAs in P. vulgaris by homology analysis. Here, 1804 known and unique plant miRNAs from 37 plant species were blast-searched against expressed sequence tag and genomic survey sequence databases to identify novel miRNAs in P. vulgaris. All candidate sequences were screened by a series of miRNA filtering criteria. Finally, we identified 27 conserved miRNAs, belonging to 24 miRNA families. When compared against known miRNAs in P. vulgaris, we found that 24 of the 27 miRNAs were newly discovered. Further, we identified 92 potential target genes with known functions for these novel miRNAs. Most of these target genes were predicted to be involved in plant development, signal transduction, metabolic pathways, disease resistance, and environmental stress response. The identification of the novel miRNAs in P. vulgaris is anticipated to provide baseline information for further research about the biological functions and evolution of miRNAs in P. vulgaris.


Subject(s)
Genome, Plant , MicroRNAs/genetics , Phaseolus/genetics , RNA, Plant/genetics , Computational Biology , Expressed Sequence Tags , MicroRNAs/chemistry , MicroRNAs/metabolism , Phaseolus/metabolism , RNA, Plant/chemistry , RNA, Plant/metabolism , Sequence Analysis, DNA
8.
Genet Mol Res ; 12(3): 3793-805, 2013 Sep 19.
Article in English | MEDLINE | ID: mdl-24085441

ABSTRACT

MicroRNAs (miRNAs) are a newly discovered class of noncoding small RNAs that regulate gene expression by directing target mRNA cleavage or translational inhibition. A large number of miRNAs have been identified in plants. Increasing evidence has shown that miRNAs play multiple roles in plant biological processes. So far, identification of miRNAs has been limited to a few model plant species, whose genomes have been sequenced. Wheat (Triticum aestivum L.) is one of the most important cereal crops worldwide. To date, only a few conserved miRNAs have been predicted in wheat. Here, we showed the conserved miRNAs identified in wheat by expressed sequence tag (EST) analysis. All previously known miRNAs from Arabidopsis, rice, and other plant species were used in a BLAST search against the wheat EST database to identify novel wheat miRNAs by a series of filtering criteria. By this strategy, we identified 62 conserved miRNAs, belonging to 30 miRNA families, 48 of which were newly discovered in wheat. These newly identified wheat miRNAs may regulate 287 potential targets, which are involved in development, signal transduction, metabolic pathways, disease resistance, ion transportation, and environmental stress response.


Subject(s)
Expressed Sequence Tags , Genome, Plant , MicroRNAs/genetics , RNA, Plant/genetics , Triticum/genetics , Arabidopsis/genetics , Evolution, Molecular , Gene Expression Regulation, Plant , Oryza/genetics , Sequence Analysis, RNA , Transcription Factors
9.
Br J Pharmacol ; 149(6): 761-74, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17016515

ABSTRACT

BACKGROUND AND PURPOSE: To further assess the clinical potential of the blockade of metabotropic glutamate receptors (mGluR1) for the treatment of pain. EXPERIMENTAL APPROACH: We characterized the effects of A-841720, a novel, potent and non-competitive mGluR1 antagonist in models of pain and of motor and cognitive function. KEY RESULTS: At recombinant human and native rat mGluR1 receptors, A-841720 inhibited agonist-induced calcium mobilization, with IC50 values of 10.7+/-3.9 and 1.0 +/- 0.2 nM, respectively, while showing selectivity over other mGluR receptors, in addition to other neurotransmitter receptors, ion channels, and transporters. Intraperitoneal injection of A-841720 potently reduced complete Freund's adjuvant-induced inflammatory pain (ED50 = 23 micromol kg(-1)) and monoiodoacetate-induced joint pain (ED50 = 43 micromol kg(-1)). A-841720 also decreased mechanical allodynia observed in both the sciatic nerve chronic constriction injury and L5-L6 spinal nerve ligation (SNL) models of neuropathic pain (ED50 = 28 and 27 micromol kg(-1), respectively). Electrophysiological studies demonstrated that systemic administration of A-841720 in SNL animals significantly reduced evoked firing in spinal wide dynamic range neurons. Significant motor side effects were observed at analgesic doses and A-841720 also impaired cognitive function in the Y-maze and the Water Maze tests. CONCLUSIONS AND IMPLICATIONS: The analgesic effects of a selective mGluR1 receptor antagonist are associated with motor and cognitive side effects. The lack of separation between efficacy and side effects in pre-clinical models indicates that mGluR1 antagonism may not provide an adequate therapeutic window for the development of such antagonists as novel analgesic agents in humans.


Subject(s)
Analgesia , Cognition/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Heterocyclic Compounds, 3-Ring/pharmacology , Motor Activity/drug effects , Receptors, Metabotropic Glutamate/antagonists & inhibitors , Animals , Cells, Cultured , Fluorescence , Humans , Male , Rats , Rats, Sprague-Dawley
14.
Methods Find Exp Clin Pharmacol ; 21(4): 285-9, 1999 May.
Article in English | MEDLINE | ID: mdl-10399137

ABSTRACT

A unilateral microinjection of either histamine or kainic acid was made into the medial vestibular nucleus of rats, eliciting robust barrel rotations that were evaluated by an elevated body-rotation test. Systemic pretreatment with betahistine or GT-2016 significantly attenuated the kainic acid-induced barrel rotations. These data indicate that the animal model described herein may represent a new model to identify novel drugs with potential antivertigo properties.


Subject(s)
Disease Models, Animal , Histamine/pharmacology , Kainic Acid/pharmacology , Vestibular Diseases/chemically induced , Vestibular Nuclei/drug effects , Animals , Betahistine/pharmacology , Drug Interactions , Excitatory Amino Acid Agonists/pharmacology , Histamine Agonists/pharmacology , Histamine Antagonists/pharmacology , Imidazoles/pharmacology , Male , Microinjections , Rats , Rats, Long-Evans , Vestibular Nuclei/pathology
15.
Environ Health Prev Med ; 4(3): 103-10, 1999 Oct.
Article in English | MEDLINE | ID: mdl-21432181

ABSTRACT

The P300 component of the event-related brain potential (ERP) is a sensitive, non-invasive, and convenient measure of cognitive dysfunction resulting from a variety of etiological agents. Application-orientated research on using the P300 measure as a cognitive probe for a wide range of neurological and psychiatric situations has been expanding rapidly in the last decade.The aim of this paper is to preview issues of application-oriented P300 research in occupational and environment medicine. Firstly, the neurophysiological background of the P300 is outlined. Secondly, the recent findings of P300 abnormalities following various occupational and environmental exposures are overviewed. Thirdly, the empirical issues for application-oriented research such as the potential causes of variability, limitation and difficulty are summarized, with suggestion for controlling them and for future standardization. Finally, it is concluded that P300 assessments demonstrate promising possibility as a sensitive marker for general cognitive dysfunction in occupational and environmental medicine.

16.
Methods Find Exp Clin Pharmacol ; 20(9): 771-7, 1998 Nov.
Article in English | MEDLINE | ID: mdl-10022031

ABSTRACT

In this paper we present a unilateral labyrinthectomy (UL) surgical procedure in rats that was derived from previous techniques. The utility of this model to assess vestibular dysfunction was evaluated by examining the ability of clinically used histaminergic agents and more selective H3 receptor antagonists to attenuate of UL-induced body rotations. Unilateral labyrinthectomy was performed by injection of ethanol into the rat right inner ear. An elevated body rotation test (EBRT) was used to assess the abnormal rotational behavior induced by UL. Scores of "3" to "0" were used to characterize the degree of abnormal behavior according to the latency of body rotations to begin. Our results demonstrate that: i) 100 microliters ethanol induced robust behavioral changes, which was used in further experiments; ii) the clinically used antivertigo agent, astemizole, significantly reduced the rotational behavior in UL rats; iii) the more potent H3 antagonists, thioperamide and GT-2016, were more efficacious than betahistine, a mixed H3 antagonist and H1 agonist. These results indicate that this model may be a potential tool for testing novel drugs for antivertigo effects and provide better support to the role of the histaminergic system in the control of vestibular function.


Subject(s)
Behavior, Animal/drug effects , Ear, Inner/physiology , Receptors, Histamine/physiology , Vertigo/drug therapy , Animals , Astemizole/pharmacology , Ear, Inner/surgery , Ethanol/pharmacology , Imidazoles/pharmacology , Male , Rats , Rats, Long-Evans , Rotation
17.
J Neuropathol Exp Neurol ; 55(3): 372-80, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8786396

ABSTRACT

Apolipoprotein E (apoE) is a plasma protein that regulates lipid transport and cholesterol homeostasis. In humans, apoE occurs as 3 major isoforms (apoE2, E3, and E4). Genetic evidence demonstrates an overrepresentation of the apoE epsilon 4 allele in Alzheimer's disease (AD). While apoE immunoreactivity (IR) is associated with the amyloid plaques and neurofibrillary tangles of AD, few studies have characterized the localization of apoE in normal human brains. We examined the distribution of apoE in the cerebral cortex of normal aged individuals and compared the results to clinically diagnosed and pathologically confirmed AD cases. In addition, we characterized the apoE IR in brains from high plaque non-demented (HPND) cases. We observed consistent and widespread apoE staining in cortical neurons from normal and HPND individuals. This finding was confirmed by double immunostaining which colocalized apoE with microtubule-associated protein-2, as well as low density lipoprotein receptor-related protein, an apoE receptor found on neurons. In contrast, AD brains displayed apoE IR in plaques and neurofibrillary tangles with little neuronal staining. These data clearly establish the presence of apoE in normal neurons, supporting an intracellular role for apoE. Moreover, the results suggest that this function of apoE is disrupted in AD, where apoE staining of neurons was drastically reduced.


Subject(s)
Alzheimer Disease/pathology , Apolipoproteins E/analysis , Cerebral Cortex/pathology , Aged , Frontal Lobe/pathology , Humans , Immunohistochemistry , Neurons/pathology
18.
Exp Neurol ; 125(2): 175-82, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8313936

ABSTRACT

Peptides corresponding to the first 40 amino acids of beta amyloid peptide (beta 1-40) and the reverse sequence (beta 40-1) were synthesized, purified, and compared for their ability to aggregate and cause toxicity in vitro to human neuroblastoma cells (SH-SY5Y), as well as for effects following injection into young or aged rats. Aggregation of both peptides produced similar sedimentation velocity profiles and resulted in significant toxicity in vitro with no observable differences between beta 1-40 and beta 40-1. In addition, when injected into the cortex of young rats, beta 1-40 was more toxic than beta 40-1 although both resulted in significant lesions. However, in aged rats the two peptides resulted in lesions of similar size. Alz 50 staining and abnormal neurites were associated with both beta 1-40 and beta 40-1 lesions; however, no evidence of plaques or tangles was found in either age group. While both peptides were toxic in vitro, only beta 1-40 elicited Alz 50 staining of SH-SY5Y cells. Electron microscopic examination of beta 1-40 and beta 40-1 aggregates showed that beta 1-40 formed fibrillar structures whereas beta 40-1 resulted in amorphous particles. Thus, although both peptides were toxic to cultured cells and aged rats, the toxicities may have resulted from different mechanisms.


Subject(s)
Amyloid beta-Peptides/pharmacology , Brain/pathology , Cell Aggregation/drug effects , Animals , Antigens/analysis , Brain/drug effects , Cell Differentiation , In Vitro Techniques , Injections , Neurites/pathology , Neuroblastoma/pathology , Neurofibrillary Tangles/drug effects , Neurofibrillary Tangles/pathology , Rats , Receptor Aggregation , Tumor Cells, Cultured
19.
Brain Res Mol Brain Res ; 18(3): 259-66, 1993 May.
Article in English | MEDLINE | ID: mdl-7684485

ABSTRACT

Alzheimer's disease and cognitive impairment in rats has been associated with an increase in the percentage of amyloid precursor protein (APP) containing the KPI domain. It has recently been reported that retinoic acid (RA) is capable of increasing the levels and altering the splicing ratio of APP in cultured SH-SY5Y cells. The effects of peripherally administered RA (64 or 640 micrograms/kg; i.p.; q.d.) on the abundance of APP, the ratio of the three major isoforms, and the relative abundance of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) were determined by rtPCR in the hippocampus of aged rats. Corresponding changes in choline acetyltransferase (ChAT) activity were also measured. Vehicle (DMSO) treated rats exhibited a 2 x (P < 0.01) increase in total APP and an 8 x (P < 0.001) decrease in the cyclophilin transcript. In addition, DMSO increased the percentage of APP 695 from 89% in saline treated rats to 94%. Treatment of RA in DMSO decreased the accumulation of total APP relative to cyclophilin at both the low (6.4 x; P < 0.01) and high (8 x; P < 0.05) dosages when compared to DMSO treated rats. Furthermore, the level of APP-695 decreased to 82% with low dosage of RA and 75% at high dosage of the total APP transcripts. No significant change in either NGF, NT-3, or BDNF transcripts were observed following low or high dosage RA administration relative to cyclophilin RNA nor was a change in ChAT activity detected at either of the dosages tested.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Alternative Splicing/drug effects , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Dimethyl Sulfoxide/pharmacology , Hippocampus/metabolism , Tretinoin/pharmacology , Amino Acid Isomerases/genetics , Amino Acid Isomerases/metabolism , Amyloid beta-Protein Precursor/isolation & purification , Animals , Base Sequence , Carrier Proteins/genetics , Carrier Proteins/metabolism , Choline O-Acetyltransferase/metabolism , Cyclosporins/metabolism , Electrophoresis, Polyacrylamide Gel , Hippocampus/drug effects , Male , Molecular Sequence Data , Oligodeoxyribonucleotides , Oligonucleotides, Antisense , Peptidylprolyl Isomerase , Polymerase Chain Reaction/methods , RNA/genetics , RNA/isolation & purification , Rats , Rats, Wistar , Reference Values
20.
Brain Res Mol Brain Res ; 16(3-4): 239-45, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1337933

ABSTRACT

The effects of peripherally administered thyroid hormone (TH; 500 micrograms/kg; i.p.; q.d.) on the relative abundances of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) RNA were determined by rtPCR in the cortex and hippocampus of young adult rats. Corresponding changes in choline acetyltransferase (ChAT) activity were measured since NGF and BDNF have been shown to enhance the expression of this marker enzyme of central cholinergic pathways. Abundance levels of NGF and NT-3, relative to cyclophilin (cycl), were increased significantly (+50%, P < 0.05) in the hippocampus following TH treatment. Despite enhanced abundance of NGF in the hippocampus, ChAT activity was unchanged, whereas ChAT activity was modestly increased by 28% in the cortex without corresponding changes in NGF, NT-3 or BDNF. These results demonstrate that TH administration is capable of inducing the accumulation of NT-3, in addition to NGF but that the induction levels of RNA cannot be directly correlated with responsivity of the cholinergic system as measured by ChAT activity.


Subject(s)
Brain/drug effects , Nerve Growth Factors/genetics , Nerve Tissue Proteins/genetics , RNA, Messenger/drug effects , Thyroxine/pharmacology , Animals , Base Sequence , Brain/metabolism , Brain-Derived Neurotrophic Factor , Choline O-Acetyltransferase/metabolism , Male , Molecular Sequence Data , Nerve Growth Factors/biosynthesis , Nerve Tissue Proteins/biosynthesis , Neurotrophin 3 , Polymerase Chain Reaction , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...